Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Young C, Argaez C. CADTH rapid response reports. In: Rapid Genome-wide Testing: A Review of Clinical Utility, Cost-Effectiveness, and Guidelines. Canadian Agency for Drugs and Technologies in Health. Ottawa, ON: Copyright© 2019 Canadian Agency for Drugs and Technologies in Health; 2019.

  2. Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol. 2017;35(20):2232–9.

    Article  Google Scholar 

  3. Chang J, Seng S, Yoo J, Equivel P, Lum SS. Clinical management of patients at risk for hereditary breast cancer with variants of uncertain significance in the era of multigene panel testing. Ann Surg Oncol. 2019;26(10):3389–96.

    Article  Google Scholar 

  4. Murphy BL, Yi M, Arun BK, Gutierrez Barrera AM, Bedrosian I. Contralateral risk-reducing mastectomy in breast cancer patients who undergo multigene panel testing. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08889-6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA

    Brittany L. Murphy MD, MS & Isabelle Bedrosian MD

Authors
  1. Brittany L. Murphy MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabelle Bedrosian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabelle Bedrosian MD.

Ethics declarations

Disclosures

B. L. Murphy and I. Bedrosian declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Murphy, B.L., Bedrosian, I. ASO Author Reflections: Performance of Contralateral Risk-Reducing Mastectomy in Multigene Panel-Tested Patients is High in All Types of Germline Mutation Carriers. Ann Surg Oncol 27 (Suppl 3), 678–679 (2020). https://doi.org/10.1245/s10434-020-08931-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08931-7

Search

Navigation